In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at the National Institutes of Health, say those outcomes would have been unimaginable about 10 years ago, prior to the drugs’ availability.

The results were published in the journal Ophthalmology and presented May 2nd at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle.

Related posts:

  1. Avastin and Lucentis are equivalent in treating age-related macular degeneration At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of […]...
  2. Medicare Card, International study reveals new genetic clues to age-related macular degeneration Medicare Card, International study reveals new genetic clues to age-related macular degeneration...
  3. Medicare Card, Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss Medicare Card, Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss...
  4. Additional Genes Associated with Age-Related Macular Degeneration Identified Additional Genes Associated with Age-Related Macular Degeneration Identified...
  5. Medicare Card, Adults stop anti-rejection drugs after partial stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients.   Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association External Web Site Policy. […]...
  6. Medicare: Cholesterol levels elevated in toddlers taking anti-HIV drugs Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions....
  7. Medicare Card, Drugs that activate brain stem cells may reverse multiple sclerosis Medicare Card, Drugs that activate brain stem cells may reverse multiple sclerosis...
  8. Medicare Card, Rehabilitation helps prevent depression from age-related vision loss Medicare Card, Rehabilitation helps prevent depression from age-related vision loss...
  9. Medicare, study uncovers new mechanism of action for class of chemotherapy drugs National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials. The study, by […]...
  10. Medicare Card, Diet, exercise, smoking habits and genes interact to affect AMD risk Medicare Card, Diet, exercise, smoking habits and genes interact to affect AMD risk...
  11. Medicare Card, Comparable effectiveness shown for two common sudden deafness treatments Direct injection of steroids into the middle ear for the treatment of sudden deafness was shown to be no more or less effective than oral steroids in restoring hearing levels in a large comparison study of patients. The study results appear in the May 25, 2011 issue of the Journal of the American Medical Association. […]...
  12. Medicare Card, NIH study provides clarity on supplements for protection against blinding eye disease Medicare Card, NIH study provides clarity on supplements for protection against blinding eye disease...
  13. Medicare, Gene Pattern, May Identify Kidney Transplant Recipients, Who Don’t Need Life-long Anti-rejection Drugs Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 […]...
  14. Medicare Card, Monthly blood transfusions reduce sickle cell anemia-related brain injury in children Medicare Card, Monthly blood transfusions reduce sickle cell anemia-related brain injury in children...
  15. Medicare Card, NIH-funded study examines frequency of follow-up bone mineral density tests Osteoporosis is characterized by reduced bone mass and bone strength leading to an increased risk of fractures. Although health care professionals have long known that low bone mineral density (BMD) is an important risk factor for bone fractures, questions have remained about how often BMD should be measured. Scientists at the Institute for Aging Research […]...